ATE274341T1
(de)
*
|
1995-02-24 |
2004-09-15 |
Elan Pharma Int Ltd |
Nanopartikel-dispersionen enthaltende aerosole
|
US6832735B2
(en)
*
|
2002-01-03 |
2004-12-21 |
Nanoproducts Corporation |
Post-processed nanoscale powders and method for such post-processing
|
US5993856A
(en)
*
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
US6000646A
(en)
*
|
1998-03-16 |
1999-12-14 |
Ranne; Bethyl H. |
Double barrel media mill for grinding and dispersing particulate matter and pigment for paint, coatings, ink and other fluid pigment vehicles
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
PL205109B1
(pl)
*
|
1998-11-02 |
2010-03-31 |
Elan Pharma Int Ltd |
Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6969529B2
(en)
*
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
DE60012520T3
(de)
|
1999-06-01 |
2009-06-25 |
Elan Pharma International Ltd. |
Kleinmühle und verfahren dafür
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
ATE453454T1
(de)
|
2000-04-26 |
2010-01-15 |
Elan Pharma Int Ltd |
Vorrichtung zur sanitären nassvermahlung
|
ES2303527T3
(es)
|
2000-05-10 |
2008-08-16 |
Jagotec Ag |
Procedimiento de molienda.
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
CA2420597C
(en)
|
2000-08-31 |
2011-05-17 |
Rtp Pharma Inc. |
Milled particles
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
JP4777602B2
(ja)
*
|
2001-01-26 |
2011-09-21 |
シェーリング コーポレイション |
ペルオキシソーム増殖因子活性化レセプター(ppar)活性化剤およびステロール吸収阻害剤の組合せおよび血管症状の処置
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
EP1381448B1
(de)
*
|
2001-04-27 |
2006-10-11 |
Kansai Paint Co., Ltd |
Verfahren und vorrichtung zum dispergieren von farbstoffen in einem flüssigen medium
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
EP1401401B1
(de)
*
|
2001-06-22 |
2005-03-30 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
US8403367B2
(en)
|
2001-08-02 |
2013-03-26 |
Eastman Kodak Company |
Authentication using near-field optical imaging
|
US6722699B2
(en)
|
2001-08-02 |
2004-04-20 |
Eastman Kodak Company |
Authentication using near-field optical imaging
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
ES2280582T3
(es)
*
|
2001-09-19 |
2007-09-16 |
Elan Pharma International Limited |
Formulaciones de insulina en nanoparticulas.
|
AU2002336609B2
(en)
*
|
2001-09-21 |
2006-08-24 |
Merck Sharp & Dohme Corp. |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
DE60222160T2
(de)
*
|
2001-10-12 |
2008-06-12 |
Elan Pharma International Ltd., Athlone |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
WO2003039601A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Imcor Pharmaceutical Company |
Methods for vascular imaging using nanoparticulate contrast agents
|
JP2005513080A
(ja)
|
2001-12-20 |
2005-05-12 |
フェムファーマ, インコーポレイテッド |
薬物の膣送達
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
EP1471887B1
(de)
|
2002-02-04 |
2010-04-21 |
Elan Pharma International Ltd. |
Arzneistoffnanopartikel mit lysozym-oberflächenstabilisator
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
US6699963B2
(en)
|
2002-03-18 |
2004-03-02 |
The Procter & Gamble Company |
Grinding process for plastic material and compositions therefrom
|
EP1487419A2
(de)
*
|
2002-03-20 |
2004-12-22 |
Elan Pharma International Limited |
Schnell auflösende dosierformen mit verringerter sprödigkeit
|
JP4842514B2
(ja)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル,リミティド |
血管新生抑制剤のナノ粒子組成物
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
EP1494649B1
(de)
|
2002-04-12 |
2012-01-04 |
Alkermes Pharma Ireland Limited |
Nanopartikuläre megestrol- formulierungen
|
DE10218109A1
(de)
*
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
DE10218107A1
(de)
*
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
JP4533134B2
(ja)
*
|
2002-06-10 |
2010-09-01 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
|
EP1551457A1
(de)
|
2002-07-16 |
2005-07-13 |
Elan Pharma International Limited |
Flüssige dosierzusammensetzungen von stabilen wirkstoffen in nanoteilchenform
|
DE60334924D1
(de)
*
|
2002-09-11 |
2010-12-23 |
Elan Pharma Int Ltd |
Anoteilchengrösse
|
JP4559227B2
(ja)
*
|
2002-10-09 |
2010-10-06 |
ノボザイムス アクティーゼルスカブ |
粒子組成物を改良する方法
|
JP4776233B2
(ja)
*
|
2002-11-12 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
摩損しにくくかつプルランを含む速崩壊性固形製剤
|
US20050095267A1
(en)
*
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
WO2004058216A2
(en)
*
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
WO2004060322A2
(en)
|
2003-01-02 |
2004-07-22 |
Femmepharma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
JP4469846B2
(ja)
*
|
2003-01-31 |
2010-06-02 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子状トピラメート製剤
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
EP1606103A4
(de)
*
|
2003-03-06 |
2007-01-10 |
Rensselaer Polytech Inst |
Rasche erzeugung von nanopartikeln aus schüttgut bei raumtemperatur
|
MXPA05009501A
(es)
*
|
2003-03-07 |
2005-10-18 |
Schering Corp |
Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
JP5137228B2
(ja)
*
|
2003-03-07 |
2013-02-06 |
メルク・シャープ・アンド・ドーム・コーポレーション |
高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
WO2004105809A1
(en)
*
|
2003-05-22 |
2004-12-09 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
DE602004018150D1
(de)
*
|
2003-08-08 |
2009-01-15 |
Elan Pharma Int Ltd |
Neue metaxalon-zusammensetzungen
|
US7618181B2
(en)
*
|
2003-10-23 |
2009-11-17 |
Kansai Paint Co., Ltd. |
Method for dispersing pigment in liquid medium
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
EP1559419A1
(de)
*
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Darreichungsformen enthaltend Metformin und ein Fibrat, sowie deren Herstellungsprozesse
|
EP1621200A1
(de)
*
|
2004-07-26 |
2006-02-01 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Kombinationen enthaltend einen Hemmstoff der Plättchenaggregation und ein Fibrat
|
EP2623095A1
(de)
*
|
2004-11-16 |
2013-08-07 |
Elan Pharma International Limited |
Injizierbare Olanzapin-Formulierungen in Nanoteilchenform
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
MX2007007342A
(es)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
JP2008526282A
(ja)
*
|
2004-12-30 |
2008-07-24 |
シンベンション アーゲー |
シグナル供給剤、インプラント材料および薬剤を含む組み合わせ
|
EP1830824B1
(de)
*
|
2004-12-31 |
2016-01-13 |
Iceutica Pty Ltd. |
Nanoteilchen-zusammensetzung und verfahren zu ihrer synthese
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
SI1836239T1
(sl)
*
|
2005-01-13 |
2009-04-30 |
Cinv Ag |
Kompozitni materiali, ki vsebujejo ogljikove nanodelce
|
BRPI0606486A2
(pt)
*
|
2005-01-24 |
2009-06-30 |
Cinv Ag |
materiais compósitos contendo metal
|
CN101189001A
(zh)
|
2005-02-15 |
2008-05-28 |
伊兰制药国际有限公司 |
纳米微粒苯并二氮杂䓬气雾剂及注射剂
|
EP1855651A4
(de)
*
|
2005-03-03 |
2011-06-15 |
Elan Pharma Int Ltd |
Nanopartikelzusammensetzungen heterocyclischer amidderivate
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
NZ561666A
(en)
*
|
2005-03-17 |
2010-05-28 |
Elan Pharma Int Ltd |
Nanoparticulate biphosphonate compositions
|
CN101142149A
(zh)
*
|
2005-03-18 |
2008-03-12 |
金文申有限公司 |
制备多孔烧结金属材料的方法
|
MX2007011772A
(es)
*
|
2005-03-23 |
2007-12-05 |
Elan Pharma Int Ltd |
Formulaciones de antihistaminico y corticosteroide de materia en nanoparticulas.
|
US7825087B2
(en)
*
|
2005-04-12 |
2010-11-02 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
WO2006110811A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate quinazoline derivative formulations
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
CA2607494A1
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel formulations
|
JP2008540691A
(ja)
*
|
2005-05-16 |
2008-11-20 |
エラン・ファルマ・インターナショナル・リミテッド |
セファロスポリンを含むナノ粒子および放出制御組成物
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
US20070042049A1
(en)
*
|
2005-06-03 |
2007-02-22 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
CN101232870A
(zh)
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
WO2007053197A2
(en)
*
|
2005-06-03 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate acetaminophen formulations
|
JP2009517485A
(ja)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
セフジトレンを含むナノ粒子状および制御放出組成物
|
ATE446742T1
(de)
*
|
2005-06-09 |
2009-11-15 |
Elan Pharma Int Ltd |
Nanopartikuläre ebastinformulierungen
|
CN101237868A
(zh)
*
|
2005-06-13 |
2008-08-06 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷和阿司匹林组合制剂
|
JP2008543862A
(ja)
*
|
2005-06-15 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アゼルニジピン製剤
|
AU2006265193A1
(en)
*
|
2005-07-01 |
2007-01-11 |
Cinvention Ag |
Process for the production of porous reticulated composite materials
|
CA2612195A1
(en)
*
|
2005-07-01 |
2007-01-11 |
Cinvention Ag |
Medical devices comprising a reticulated composite material
|
WO2007008537A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
US20070104792A1
(en)
*
|
2005-09-13 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
JP2009508859A
(ja)
*
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アリピプラゾール製剤
|
EP1937753A1
(de)
*
|
2005-10-18 |
2008-07-02 |
Cinvention Ag |
Duroplastische teilchen und herstellungsverfahren dafür
|
AU2006318349B2
(en)
|
2005-11-28 |
2010-08-19 |
Marinus Pharmaceuticals |
Ganaxolone formulations and methods for the making and use thereof
|
WO2007089335A2
(en)
|
2005-12-29 |
2007-08-09 |
Lexicon Pharmaceutical Inc. |
Multicyclic amino acid derivatives and methods of their use
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US20070264349A1
(en)
*
|
2006-03-07 |
2007-11-15 |
Novavax, Inc. |
Nano-structured compositions and methods of making and using the same
|
EP2040675A1
(de)
*
|
2006-05-30 |
2009-04-01 |
Elan Pharma International Limited |
Nanoteilchenförmige posaconazol-formulierungen
|
JP5508003B2
(ja)
|
2006-06-30 |
2014-05-28 |
アイスイティカ ピーティーワイ リミテッド |
ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法
|
WO2008008733A2
(en)
*
|
2006-07-10 |
2008-01-17 |
Elan Pharma International Ltd. |
Nanoparticulate sorafenib formulations
|
MX2009000391A
(es)
*
|
2006-07-12 |
2009-06-30 |
Elan Pharma Int Ltd |
Formulación de modafinilo en forma de nano-partículas.
|
AU2007325628A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
UA99270C2
(en)
|
2006-12-12 |
2012-08-10 |
Лексикон Фармасьютикалз, Инк. |
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
|
CN101646402A
(zh)
*
|
2007-01-19 |
2010-02-10 |
金文申有限公司 |
用粉末模塑法制成的多孔、不可降解植入物
|
CN101652467A
(zh)
*
|
2007-02-28 |
2010-02-17 |
金文申有限公司 |
含有填料的高表面积培养系统
|
WO2008104588A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system
|
WO2008104599A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system bag
|
US20080206735A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Cinvention Ag |
High surface cultivation system with surface increasing substrate
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
EP2398499B1
(de)
|
2009-02-18 |
2017-09-06 |
Eyeon Particle Sciences LLC |
Verwendung von bifunktionellem copolymer für augenärztliche und andere topische sowie lokale anwendungen
|
EP2448406B1
(de)
|
2009-02-26 |
2016-04-20 |
Relmada Therapeutics, Inc. |
Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
|
EP2435027B1
(de)
|
2009-05-27 |
2016-10-05 |
Alkermes Pharma Ireland Limited |
Reduzierung der flockenartigen aggregation in nanoteilchenförmigen meloxicam-zusammensetzungen
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
MX2011013260A
(es)
|
2009-06-12 |
2012-02-28 |
Adagio Pharmaceuticals Ltd |
Apomorfina sublingual.
|
HUP0900376A2
(en)
|
2009-06-19 |
2011-01-28 |
Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag |
Nanoparticulate candesartan cilexetil composition
|
WO2010146406A1
(en)
|
2009-06-19 |
2010-12-23 |
Nanoform Hungary Ltd. |
Nanoparticulate telmisartan compositions and process for the preparation thereof
|
EP2442793A1
(de)
|
2009-06-19 |
2012-04-25 |
Nanoform Hungary Ltd. |
"nanostrukturierte sildenafilbasis, pharmazeutisch akzeptable salze und co-kristalle daraus, ihre zusammensetzungen; herstellungsverfahren dafür und pharmazeutische zusammensetzungen damit "
|
HUP0900384A2
(en)
|
2009-06-19 |
2011-01-28 |
Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag |
Nanoparticulate olmesartan medoxomil compositions
|
JP2013510092A
(ja)
|
2009-11-05 |
2013-03-21 |
レクシコン ファーマシューティカルズ インコーポレイテッド |
がんの治療のためのトリプトファンヒドロキシラーゼ阻害剤
|
US20130137635A1
(en)
|
2010-02-10 |
2013-05-30 |
Lexicon Pharmaceuticals, Inc. |
Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
|
EP2560624B1
(de)
|
2010-04-23 |
2018-07-04 |
KemPharm, Inc. |
Therapeutische formulierung für reduzierte medikamenten-nebenwirkungen
|
US9511037B2
(en)
|
2010-04-23 |
2016-12-06 |
Genco Sciences Llc |
Compositions for reduction of side effects
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
HUP1000299A2
(hu)
|
2010-06-08 |
2012-02-28 |
Nanoform Cardiovascular Therapeutics Ltd |
Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
|
HUP1000325A2
(en)
|
2010-06-18 |
2012-01-30 |
Druggability Technologies Ip Holdco Jersey Ltd |
Nanostructured aprepitant compositions and process for their preparation
|
HUP1000327A2
(en)
|
2010-06-18 |
2012-01-30 |
Druggability Technologies Ip Holdco Jersey Ltd |
Composition containing nanostructured ezetibime and process for it's preparation
|
US20120067343A1
(en)
|
2010-09-22 |
2012-03-22 |
Map Pharmaceuticals, Inc. |
Aerosol Composition for Administering Drugs
|
DE102010052656A1
(de)
*
|
2010-11-26 |
2012-05-31 |
Netzsch-Feinmahltechnik Gmbh |
Hydraulische Mahlkugel Zu- und Abfuhr für Rührwerkskugelmühlen
|
KR102025238B1
(ko)
|
2010-12-16 |
2019-09-25 |
선오비온 파마슈티컬스 인코포레이티드 |
설하 필름
|
US9562015B2
(en)
|
2011-11-17 |
2017-02-07 |
The Regents Of The University Of Colorado, A Body |
Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
|
US10022303B2
(en)
*
|
2012-02-28 |
2018-07-17 |
Iceutica Pty Ltd. |
Inhalable pharmaceutical compositions
|
WO2013148978A1
(en)
|
2012-03-30 |
2013-10-03 |
Lexicon Pharmaceuticals, Inc. |
Methods and compositions for the treatment of necrotizing enterocolitis
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
CA2900652C
(en)
|
2013-02-15 |
2021-05-04 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
JP2016510000A
(ja)
|
2013-02-20 |
2016-04-04 |
カラ ファーマシューティカルズ インコーポレイテッド |
治療用化合物およびその使用
|
BR112015020572B1
(pt)
*
|
2013-02-28 |
2022-02-22 |
Sun Chemical Corporation |
Processo contínuo para transformar sólido moído em dispersão líquida e aparelho
|
KR101741344B1
(ko)
|
2013-06-28 |
2017-05-29 |
렉산 파마슈티컬스, 인코포레이티드 |
피페라진 화합물의 나노미립자 조성물 및 제제
|
KR20160099084A
(ko)
|
2013-11-01 |
2016-08-19 |
칼라 파마슈티컬스, 인크. |
치료 화합물의 결정질 형태 및 그의 용도
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
HU231309B1
(hu)
|
2014-02-25 |
2022-11-28 |
Darholding Kft. |
Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra
|
US20150343453A1
(en)
*
|
2014-05-28 |
2015-12-03 |
NanoCentrix L.L.C. |
Fluid energy media mill system and method
|
SI3182958T2
(sl)
|
2014-08-18 |
2022-07-29 |
Alkermes Pharma Ireland Limited |
Sestavki aripiprazol predzdravila
|
US10016415B2
(en)
|
2014-08-18 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
CA3019769C
(en)
|
2015-04-21 |
2021-10-12 |
Sunovion Pharmaceuticals Inc. |
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
|
EP3288957A4
(de)
|
2015-05-01 |
2019-01-23 |
Cocrystal Pharma, Inc. |
Nukleosidanaloga zur behandlung von viren der flaviviidae-familie und krebs
|
US11034701B2
(en)
|
2015-06-16 |
2021-06-15 |
Nanophagix LLC |
Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
|
CN108135838A
(zh)
|
2015-10-16 |
2018-06-08 |
马瑞纳斯制药公司 |
包含纳米粒的可注射神经类固醇制剂
|
ES2893973T3
(es)
|
2016-02-17 |
2022-02-10 |
Alkermes Pharma Ireland Ltd |
Composiciones de múltiples profármacos de aripiprazol
|
AU2017311412B2
(en)
|
2016-08-11 |
2023-05-18 |
Ovid Therapeutics Inc. |
Methods and compositions for treatment of epileptic disorders
|
CA3036340A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
CA3036336A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
EP3509421A4
(de)
|
2016-09-08 |
2020-05-20 |
Kala Pharmaceuticals, Inc. |
Kristalline formen therapeutischer verbindungen und verwendungen davon
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
EA038692B1
(ru)
|
2016-09-13 |
2021-10-05 |
Киова Кирин Ко., Лтд. |
Фармацевтическая композиция
|
EP3732180A4
(de)
|
2017-12-27 |
2022-05-11 |
Emory University |
Kombinierte modalitäten für nukleoside- und/oder nadph-oxidase (nox)-inhibitoren als myeloidspezifische antivirale mittel
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
JP2022543837A
(ja)
|
2019-08-05 |
2022-10-14 |
マリナス ファーマシューティカルズ, インコーポレイテッド |
てんかん重積状態の治療に使用するためのガナキソロン
|
US20230339880A1
(en)
|
2019-10-11 |
2023-10-26 |
Corbus Pharmaceuticals, Inc. |
Compositions of ajulemic acid and uses thereof
|
IL293525A
(en)
|
2019-12-06 |
2022-08-01 |
Marinus Pharmaceuticals Inc |
Ganaxolone for use in the treatment of multiple sclerosis complex
|
EP3928772B1
(de)
|
2020-06-26 |
2024-06-19 |
Algiax Pharmaceuticals GmbH |
Nanopartikuläre zusammensetzung
|
CN112427096B
(zh)
*
|
2020-10-19 |
2022-01-28 |
上海旭军机械有限公司 |
一种纳米材料的研磨设备
|